| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/05/2010 | EP2181715A1 Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens |
| 05/05/2010 | EP2181714A2 Immunogenic composition for use in vaccination against staphylococcei |
| 05/05/2010 | EP2181711A1 Cancer therapy using whole glucan particles and antibodies |
| 05/05/2010 | EP2181595A1 Tumor associated antigen, peptides thereof, and use of same as anti-tumor vaccines |
| 05/05/2010 | EP2181331A1 Materials and methods for sperm sex selection |
| 05/05/2010 | EP2181189A1 Recombinant north american type 1 porcine reproductive and respiratory syndrome virus and methods of use |
| 05/05/2010 | EP2181121A2 Chimeric antigens |
| 05/05/2010 | EP2181120A2 Allergens from aspergillus versicolor, and method of detecting a mold allergy caused by interior rooms |
| 05/05/2010 | EP2180901A2 Conjugate purification |
| 05/05/2010 | EP1996711B1 Novel plant virus particles and methods of inactivation thereof |
| 05/05/2010 | EP1702982B1 Method of detecting liver cancer, diagnostic for liver cancer and remedy for cancer |
| 05/05/2010 | EP1572106B1 Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis |
| 05/05/2010 | EP1567545B1 Peptides and their use in the treatment of central nervous system damage |
| 05/05/2010 | EP1461054B1 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation |
| 05/05/2010 | EP1427817B1 Multiplication of viruses in a cell culture |
| 05/05/2010 | EP1248803B1 Nogo receptor-mediated blockade of axonal growth |
| 05/05/2010 | EP0946185B2 PHARMACEUTICAL COMPOSITION COMPRISING A COMPOUND HAVING ANTI-Xa ACTIVITY AND A PLATELET AGGREGATION ANTAGONIST COMPOUND |
| 05/05/2010 | CN1976687B Immune response stimulating composition comprising nanoparticles based on a methyl vinyl ether-maleic acid copolymer |
| 05/05/2010 | CN1798548B Immunogenic compositions based on microparticles comprising adsorbed toxoid and a polysaccharide-containing antigen |
| 05/05/2010 | CN1752104B Monoclonal antibody of synapse protein gamma and its application |
| 05/05/2010 | CN1708587B Recombinant MVA strains as potential vaccines against p. falciparum malaria |
| 05/05/2010 | CN1548537B Vaccine preparing process and antitumor vaccine |
| 05/05/2010 | CN1446261B Modified cytokines for use in cancer therapy |
| 05/05/2010 | CN101702906A Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteins |
| 05/05/2010 | CN101700401A Polyalkylene glycol with moiety for conjugating biologicallyactive compound |
| 05/04/2010 | US7709622 Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis |
| 05/04/2010 | US7709611 antibodies and antigen binding domains and CDR regions that mediate selective binding to an epitope located in the carboxyl half of the Dkk-1 protein; for bone disorders, inflammatory, neurological, ocular, renal, pulmonary and skin diseases |
| 05/04/2010 | US7709610 As an antagonist that inhibits immunoglobulin secretion; autoimmune disorders; antiproliferative , anticarcinogenic and antiarthritic agents; inflammatory bowel disease |
| 05/04/2010 | US7709451 Method and composition for treating immune complex associated disorders |
| 05/04/2010 | US7709445 Colloidal suspension of nanoparticles based on an amphiphilic copolymer |
| 05/04/2010 | US7709270 Using platelete derived growth factor as tool in detection of modulators for prevention and treatment of cell proliferative disorders |
| 05/04/2010 | US7709226 Selecting variable region framework sequences from human antibody genes by comparing canonical CDR structure types for corresponding CDRs from a library of human germline antibody sequences; converting an antibody sequence of any subject species to a less immunogenic form |
| 05/04/2010 | US7709216 Methods for preventing or reducing ischemia/reperfusion induced myocardial cell death |
| 05/04/2010 | US7709214 Using antibody specific blocking agents to treat and prevent infection, cell proliferative and immunosuppressive disorders |
| 05/04/2010 | US7709211 Proteins expressed by mycobacterium tuberculosis and not by BCG and their use as diagnostic reagents and vaccines |
| 05/04/2010 | US7709196 rRNA genes from E. coli and other disease causing organisms are genetically engineered to allow identification of functional mutant ribosomes that may be used as drug targets |
| 05/04/2010 | US7709031 Angiogenic agents from plant extracts, gallic acid, and derivatives |
| 05/04/2010 | US7709009 Immunogenic compositions for streptococcus pyogenes |
| 05/04/2010 | US7709008 An recombinant serine-aspartate repeat (Sdr) protein from Staphylococcus epidermidis which is cell-wall associated, wherein the protein comprises the amino acid sequence 10-1742 of SEQ ID NO: 4.; multicomponent vaccines; coating polymericbiomaterials; catheters; prosthetics; nucleic acid probes |
| 05/04/2010 | US7709007 Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences |
| 05/04/2010 | US7709006 Hepatitis-C virus testing |
| 05/04/2010 | US7709004 Method of producing an HIV-1 immune response |
| 05/04/2010 | US7709003 Method of producing an HIV-1 immune response |
| 05/04/2010 | US7709002 Mutated ras peptides for generation of CD8+Cytotoxic T lymphocytes |
| 05/04/2010 | US7709001 formulated as a vaccine, increases coverage against pneumococcal disease in infants and young children; provides coverage for serotypes 6A and 19A; periodic acid oxidation of the polysaccharide in the presence of bivalent cations |
| 05/04/2010 | US7709000 Using MG1(mucin) specific immunoglobulins to target therapeutic agents to tumor cells |
| 05/04/2010 | US7708999 Inhibiting activity of fibroblast growth factor 8; preventing joint destruction, protecting cartilage, inhibiting growth of synovial membrane; diagnostic agent; antibody active ingredient |
| 05/04/2010 | US7708998 Methods of inhibiting unwanted cell proliferation using hedgehog antagonists |
| 05/04/2010 | US7708997 antibody composition comprising a Fc region with complex N-glycoside-linked sugar chains bound to the Fc region through N-acetylglucosamines of the reducing terminal of the sugar chains |
| 05/04/2010 | US7708996 Tumor necrosis factor receptor specific immunoglobulins for use in treatment and prevention of cancers, autoimmune, viral, inflammatory, graft vs host and nervous system disorders |
| 05/04/2010 | US7708995 Use of TNF-alpha inhibitors for treating a nerve disorder mediated by nucleus pulposus |
| 05/04/2010 | US7708994 Therapy of autoimmune disease in a patient with an inadequate response to a TNF-α inhibitor |
| 05/04/2010 | US7708993 Polypeptides involved in immune response |
| 05/04/2010 | US7708992 Methods for producing antibody compositions with increased ADCC |
| 05/04/2010 | US7708991 Method for treating cancer and identifying novel anti-cancer compounds |
| 05/04/2010 | US7708987 ras-mediated; administering immunosuppressive for immune constituents that may interfere with the systemic delivery of the reovirus; antiproliferative; in the neoplastic cells phosphorylation of PKR is prevented by inactivation or deletion of PKR; antitumor agents |
| 05/04/2010 | US7708983 Directional induction of immune response by co-administration of antigens with chemokines |
| 05/04/2010 | US7708960 A dry heat sterilization system having a housing and a number of plenums to guide the flow of hot air, which is forced to flow through the plenums, the intake slide duct and into the bottom of the containers, hot air will rise and exit from the top of the container through the exhaust slide duct |
| 05/04/2010 | US7707970 immunogens |
| 05/04/2010 | CA2448863C Increased and sustained in vivo gene expression using a nucleic acid, histone, and amphipathic compound composition |
| 05/04/2010 | CA2335364C Use of bi-specific antibodies for pre-targeting diagnosis and therapy |
| 05/04/2010 | CA2319057C Compositions comprising a poly(oxyethylene)-poly(oxypropylene) block copolymer and their use |
| 05/04/2010 | CA2223503C Transferrin receptor genes |
| 05/04/2010 | CA2172398C Methods and products for controlling immune responses in mammals |
| 04/29/2010 | WO2010048615A2 Human ebola virus species and compositions and methods thereof |
| 04/29/2010 | WO2010048572A1 A novel anti-viral method |
| 04/29/2010 | WO2010048520A1 Lipidated imidazoquinoline derivatives |
| 04/29/2010 | WO2010048479A1 METHODS FOR DETERMINING THE LEVELS OF TGF-β IN A COMPOSITION |
| 04/29/2010 | WO2010048446A2 Modulation of axon degeneration |
| 04/29/2010 | WO2010048424A1 Methods, compositions, and kits for diagnosing, monitoring, and treating disease |
| 04/29/2010 | WO2010048394A2 Vaccine against african horse sickness virus |
| 04/29/2010 | WO2010047955A2 N-linked glycosylation alteration in e0 and e2 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine |
| 04/29/2010 | WO2010047829A1 Mutant hepatitis c virus e2 polypeptides for hcv treatment |
| 04/29/2010 | WO2010047698A1 Activation-induced cytidine deaminase inhibitor suppression of autoimmune diseases |
| 04/29/2010 | WO2010047509A2 Anti-dr5 antibody with improved affinity and stability, and composition for cancer prevention or treatment including same |
| 04/29/2010 | WO2010047310A1 Tumor antigen peptide and use thereof |
| 04/29/2010 | WO2010047117A1 Novel monoclonal antibody and use thereof |
| 04/29/2010 | WO2010047062A1 Rab6kifl/kif20a epitope peptide and vaccines containing the same |
| 04/29/2010 | WO2010046935A1 Combination vaccine with acellular pertussis |
| 04/29/2010 | WO2010046934A1 Combination vaccine with whole cell pertussis |
| 04/29/2010 | WO2010046771A1 Immunization protocol for directed expansion and maturation |
| 04/29/2010 | WO2010046715A1 Vaccine compositions comprising a mutated factor h binding protein |
| 04/29/2010 | WO2010046592A2 Use of isolated polypeptides having antigenic properties against mycoplasma pneumoniae, and of corresponding polynucleotides and antibodies |
| 04/29/2010 | WO2010046474A2 Chemoattractants inhibitors |
| 04/29/2010 | WO2010046338A1 Composition for targeting dendritic cells |
| 04/29/2010 | WO2010046335A1 Production of influenza virus by reverse genetics in per.c6 cells under serum free conditions |
| 04/29/2010 | WO2010046039A1 Mycobacterium tuberculosis vaccine |
| 04/29/2010 | WO2010045881A1 A vaccine composition against foot-and-mouth disease and the preparation method thereof |
| 04/29/2010 | WO2010022210A3 Diagnosis and monitoring of renal failure using peptide biomarkers |
| 04/29/2010 | WO2010019717A3 Combination therapy of hiv fusion/entry inhibitors targeting gp41 |
| 04/29/2010 | WO2010009346A3 Hiv vaccine based on targeting maximized gag and nef to dendritic cells |
| 04/29/2010 | WO2010005570A3 Compositions comprising antibodies to lingo or fragments thereof |
| 04/29/2010 | WO2010004276A3 Antibody |
| 04/29/2010 | WO2010004204A3 Fgf-r4 receptor-specific antagonists |
| 04/29/2010 | WO2009149382A3 Anti-cd8 antibodies block priming of cytotoxic effectors and lead to generation of regulatory cd8+t cells |
| 04/29/2010 | WO2009144462A3 Laminin receptor binding proteins |
| 04/29/2010 | WO2009143483A3 PsrP IS A PROTECTIVE ANTIGEN AGAINST PNEUMOCOCCAL INFECTION |
| 04/29/2010 | WO2009143457A3 Vaccine composition containing synthetic adjuvant |
| 04/29/2010 | WO2009143413A8 Synergistic immunogenic fusion protein-polysaccharide conjugate |
| 04/29/2010 | WO2009142460A3 Antibody-peptide fused synergibody |